Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00104572
What this trial is testing

Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.

Who this might be right for
HypogonadismDiabetesSarcopenia+2 more
National Institute on Aging (NIA) 44
Large-scale testing (Phase 3)Looking for participantsNCT07647328
What this trial is testing

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Who this might be right for
ER-Positive HER2-Negative Breast Cancer
AstraZeneca 150
Post-approval studies (Phase 4)UnknownNCT04671966
What this trial is testing

Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction

Who this might be right for
Heart DiseasesLeft Ventricular Dysfunction
The University of Texas at Arlington 100
Testing effectiveness (Phase 2)Study completedNCT02730429
What this trial is testing

Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 78
Testing effectiveness (Phase 2)WithdrawnNCT01953445
What this trial is testing

Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Washington University School of Medicine
Not applicableLooking for participantsNCT06690866
What this trial is testing

Negative Emotionality and Epigenetics During Puberty

Who this might be right for
PubertyHealthyStress
International Research Training Group 2804 100
Not applicableStudy completedNCT03523195
What this trial is testing

Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+16 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00001181
What this trial is testing

Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty

Who this might be right for
Polyostotic Fibrous DysplasiaPrecocious Puberty
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 100
Not applicableStudy completedNCT03719495
What this trial is testing

Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast CancerHealthy
Duke University 68
Testing effectiveness (Phase 2)WithdrawnNCT03377101
What this trial is testing

Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeProgesterone Receptor Positive+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00068601
What this trial is testing

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerInfertilityMenopausal Symptoms
SWOG Cancer Research Network 257
Not applicableEnded earlyNCT04639661
What this trial is testing

Predictors of Periodontal Outcomes Post-sanative Therapy

Who this might be right for
Periodontal DiseasesPeriodontal Pocket
Brock University 12
Not applicableStudy completedNCT01899079
What this trial is testing

A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay

Who this might be right for
Breast Cancer
NanoString Technologies, Inc. 217
Testing effectiveness (Phase 2)Active Not RecruitingNCT04567420
What this trial is testing

DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

Who this might be right for
Breast Cancer
Criterium, Inc. 70
Early research (Phase 1)Study completedNCT02248090
What this trial is testing

AZD9496 First Time in Patients Ascending Dose Study

Who this might be right for
ER+ HER2- Advanced Breast Cancer
AstraZeneca 45
Testing effectiveness (Phase 2)Study completedNCT00632723
What this trial is testing

IRESSA™ (Gefitinib) in Breast Cancer Patients

Who this might be right for
Breast Cancer
AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT02871791
What this trial is testing

Palbociclib With Everolimus + Exemestane In BC

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastHormone Receptor (HR)-Positive Breast Cancer
Dana-Farber Cancer Institute 41
Testing effectiveness (Phase 2)Ended earlyNCT00379197
What this trial is testing

Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Study completedNCT03844685
What this trial is testing

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88
Not applicableWithdrawnNCT01159236
What this trial is testing

Molecular Triaging of Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Next Page